Definately not chit chat:
eurekalert.org
Now, a study on mice by Angelo Vescovi, of NeuroSpheres
Limited in Canada and the National Neurological Institute in Italy,
and his colleagues suggests that stem cells don't have to come from
embryos in order to generate specialized cells. "We went the other
way around and used adult stem cells instead," said Vescovi.
Hey dudes, time to make the thread a little more active...eh?
corporate-ir.net
In March 1994, the Company obtained an exclusive, worldwide license from NeuroSpheres, Ltd. for the commercial development and use of its proprietary neural stem cells for transplantation to treat human disease. In 1997, through the acquisition of StemCells, Inc., a company focused on the discovery and development of stem cells, CytoTherapeutics acquired additional intellectual property and licenses related to neural stem/progenitor cells.
corporate-ir.net
In March 1994, CytoTherapeutics announced that it had licensed a portfolio of patent applications from NeuroSpheres, Ltd. of Canada. CytoTherapeutics' neural stem patent estate currently consists of 7 issued U.S. patents and 13 pending U.S. patent applications related to stem/progenitor cells of the central and peripheral nervous systems.
--Mike |
